Key facts
- This page summarizes Christopher B. Ehrlich's Form 4 filing for eFFECTOR Therapeutics, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 06 Oct 2022, 08:30.
Christopher B. Ehrlich - 04 Oct 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 04 Oct 2022
- Net transaction value
- +$197
- SEC form
- 4
- Accepted by SEC
- 06 Oct 2022, 08:30:09 UTC
- Prior SEC filing
- 27 Sep 2022
- Next SEC filing
- 24 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Byrnes, Attorney-in-Fact for Christopher B. Ehrlich
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Christopher B. Ehrlich filed Form 4 for eFFECTOR Therapeutics, Inc. on 06 Oct 2022.
Change
- Previous filing in this sequence was filed on 27 Sep 2022.
- Current net transaction value: +$197.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EFTR
transaction
Common Stock
Purchase
- Transaction value
- $197
- Shares
- +346
- Change %
- +0.99%
- Price
- $0.5700
- Shares after
- 35,213
- Date
- 04 Oct 2022
- Ownership
- Direct
EFTR
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 142,168
- Date
- 04 Oct 2022
- Ownership
- By Locust Walk Partners LLC
- Footnotes
- F1
EFTR
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,034
- Date
- 04 Oct 2022
- Ownership
- By Locust Walk Partners LLC
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents shares held directly by the Sponsor, of which Locust Walk Partners LLC ("LWP") is a member. LWP has allocated these shares to the reporting person.
Footnote F2
Represents shares held directly by the Sponsor, of which LWP is a member. LWP has allocated these shares to the reporting person's spouse.